cyproheptadine has been researched along with Metabolic Diseases in 2 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both groups of carcinoid patients had a comparable decrease in their insulinogenic index." | 1.25 | Glucose intolerance in the carcinoid syndrome. ( Bivens, CH; Feldman, JM; Lebovitz, HE; Plonk, JW, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morphy, R | 1 |
| Rankovic, Z | 1 |
| Feldman, JM | 1 |
| Plonk, JW | 1 |
| Bivens, CH | 1 |
| Lebovitz, HE | 1 |
1 review available for cyproheptadine and Metabolic Diseases
| Article | Year |
|---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, N | 2005 |
1 other study available for cyproheptadine and Metabolic Diseases
| Article | Year |
|---|---|
Glucose intolerance in the carcinoid syndrome.
Topics: Adult; Aged; Carcinoid Tumor; Cyproheptadine; Diabetes Mellitus; Female; Fenclonine; Glucose; Glucos | 1975 |